Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.768
+0.026 (3.52%)
At close: Apr 28, 2026, 4:00 PM EDT
0.755
-0.014 (-1.78%)
Pre-market: Apr 29, 2026, 5:28 AM EDT
Onconetix Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.82 | 2.52 | 0.06 | - | - | |
| Revenue Growth (YoY) | -67.70% | 4217.31% | - | - | - | |
| Cost of Revenue | 0.18 | 1.47 | 1.19 | - | - | |
| Gross Profit | 0.63 | 1.06 | -1.13 | - | - | |
| Selling, General & Admin | 7.04 | 11.23 | 14.77 | 9.05 | 2.09 | |
| Research & Development | -0.07 | 0.15 | 1.95 | 4.13 | 1.33 | |
| Operating Expenses | 6.98 | 11.39 | 16.72 | 13.18 | 3.42 | |
| Operating Income | -6.34 | -10.33 | -17.85 | -13.18 | -3.42 | |
| Interest Expense | -0.75 | -1.41 | -0.67 | - | - | |
| Interest & Investment Income | 0 | 0 | - | - | - | |
| Other Non Operating Income (Expenses) | 9.76 | 1.42 | -0.09 | 0.06 | - | |
| EBT Excluding Unusual Items | 2.66 | -10.32 | -18.61 | -13.12 | -3.42 | |
| Impairment of Goodwill | -11.51 | -32.35 | - | - | - | |
| Asset Writedown | - | -13.81 | -14.69 | - | - | |
| Other Unusual Items | -5.18 | -3.26 | -4.12 | -0.3 | - | |
| Pretax Income | -14.03 | -59.74 | -37.42 | -13.42 | -3.42 | |
| Income Tax Expense | 0 | -1.05 | -0.01 | - | - | |
| Net Income | -14.03 | -58.69 | -37.41 | -13.42 | -3.42 | |
| Preferred Dividends & Other Adjustments | 1.5 | 0.21 | - | 0.1 | 0.63 | |
| Net Income to Common | -15.53 | -58.9 | -37.41 | -13.52 | -4.04 | |
| Shares Outstanding (Basic) | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 0 | - | - | - | - | |
| EPS (Basic) | -82.81 | - | - | - | - | |
| EPS (Diluted) | -82.81 | - | - | - | - | |
| Free Cash Flow | -9.68 | -10.52 | -23.16 | -8.68 | -2.05 | |
| Free Cash Flow Per Share | -51.61 | - | - | - | - | |
| Gross Margin | 77.62% | 41.80% | - | - | - | |
| Operating Margin | -778.16% | -409.30% | -30526.38% | - | - | |
| Profit Margin | -1904.77% | -2333.39% | -63986.48% | - | - | |
| Free Cash Flow Margin | -1186.99% | -416.95% | -39620.44% | - | - | |
| EBITDA | -6.33 | -9.6 | -17.8 | -13.17 | -3.41 | |
| D&A For EBITDA | 0.02 | 0.73 | 0.04 | 0.01 | 0 | |
| EBIT | -6.34 | -10.33 | -17.85 | -13.18 | -3.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.